1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Capillary Leak Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finkelman, FD; Morris, SC; Smiley, K; Strait, RT; Urban, JF | 1 |
| Battistini, B; O'Brien, JG; Plante, GE; Sirois, P; Zaharia, F | 1 |
| Kolaczkowska, E; Plytycz, B; Seljelid, R; Shahzidi, S; van Rooijen, N | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Capillary Leak Syndrome
| Article | Year |
|---|---|
IL-4 exacerbates anaphylaxis.
Topics: Adjuvants, Immunologic; Anaphylaxis; Animals; Capillary Leak Syndrome; Dose-Response Relationship, Immunologic; Drug Therapy, Combination; Female; Injections, Intravenous; Interleukin-12; Interleukin-13; Interleukin-18; Interleukin-4; Leukotriene C4; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, Nude; Mice, Transgenic; Platelet Activating Factor; Serotonin; Signal Transduction; STAT6 Transcription Factor; Trans-Activators | 2003 |
Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats.
Topics: Animals; Antifibrinolytic Agents; Aorta; Aprotinin; Bronchi; Capillary Leak Syndrome; Capillary Permeability; Coloring Agents; Duodenum; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Male; Microcirculation; Organ Specificity; Pancreas; Platelet Activating Factor; Postoperative Complications; Pulmonary Circulation; Rats; Rats, Wistar; Time Factors; Tranexamic Acid | 2000 |
Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Capillary Leak Syndrome; Capillary Permeability; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cysteine; Diterpenes; Eicosanoids; Enzyme Induction; Ginkgolides; Histamine Release; Indoles; Indomethacin; Isoenzymes; Lactones; Leukotriene C4; Leukotrienes; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Male; Mast Cells; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Nitrobenzenes; Peritonitis; Phospholipid Ethers; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Quinolines; Sulfonamides; Thioglycolates; Zymosan | 2002 |